Skip to main content

Table 2 Data analyses examining the impact on care processes and outcomes (pre versus post-March 2020)

From: Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study

RE-AIM dimension

Example areas to be studied

Outcome

(implementation or participant level)

Key features and subgroups associated with outcomes

Data sources

Reach

Changes in the population served

Implementation: Program level rates of enrollment and discharge across OTNY

Geographic areas with high and low COVID penetration.

Clinician-reported data aggregated to the program level

Effectiveness

Participant level: Participant characteristics at enrollment to OTNY

Referral source (e.g., inpatient unit), duration of untreated psychosis (DUP), symptoms, additional variables as identified in Aims 1 and 2

Clinician-reported data and participant self-report data

Effectiveness

Participant level: Participant features at time of discharge/disengagement from OTNY

Length of stay in OnTrackNY; symptoms, occupational and social functioning; use of telehealth services; satisfaction with services; other factors as identified in Aims 1 and 2

Clinician-reported data and participant self-report data

Effectiveness

Changes

in participant outcomes

Participant level: Symptoms, social and occupational functioning, work/school participation, suicidality, and other factors identified in Aims 1 and 2

Clinical characteristics at enrollment, age, gender, race/ethnicity, DUP, educational attainment, program site, presence of identified modifications, other factors as identified in Aims 1 & 2

Clinician and participant self-reported data

Implementation

Changes in how and which services are implemented

Implementation level: Frequency of utilization of OTNY services overall and with particular team members (e.g., peer support, supported employment and education services)

Presence of identified modifications in a clinic (e.g., telehealth interventions), programs where staffing was affected (e.g., FTE per team), participant utilization of modifications, fidelity to the CSC model, other factors identified in Aims 1 & 2

Program-level data and clinician-reported data